Published on : Aug 09, 2017
Albany, New York, August 9, 2017: A new study, titled “Urea Cycle Disorders-Market Insights, Epidemiology and Market Forecast-2025” has been freshly broadcasted to the wide repository of Market Research Hub (MRH), offering readers an in-depth perspective of the Urea Cycle Disorders. The study also enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Urea cycle disorders worldwide. Additionally, overall market outlook section provides an understanding of country specific revenue and share by analyzing performance of the current therapies and potential uptake of new products in the market.
Geographically, the report provides an overview of the disease and exhaustive research related to urea cycle disorder for the seven major markets for the study period undertaken from 2015-2025. It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of urea cycle disorder for 7 major markets, which are United States, EU 5 (Germany, Spain, Italy, France and the United Kingdom) and Japan. According to analyst’s findings, the forecasted patient population of this disorder will grow at a rapid rate from 2015 to 2025. Also, the 7MM market size is estimated to reach a high value by the end of 2025.
In a healthy individual, the liver supplies some enzymes to change nitrogen into urea, which is then removed from the body in urine. This entire process is called the urea cycle. A urea cycle disorder (UCD) is an inherited disease that affects how the body removes the waste that is made from breaking down protein. In urea cycle disorder, nitrogen accumulates in the form of ammonia. Ammonia is then reaches the brain through the blood, where it can cause permanent brain damage, coma and/or death. It is believed that up to 20% of Sudden Infant Death Syndrome (SIDS) cases may be attributed to an undiagnosed inborn error of metabolism such a urea cycle disorder which is expected to drive the urea cycle disorders treatment market for over the forecast period.
Moreover, understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Urea Cycle Disorders are included in the study. The report analyses some of the treatment process, which includes drug treatment, liver transplant, dietary and respiratory management. Sodium phenylbutyrate or buphenyl is an ammonia scavenger that is widely used to treat UCDs. It provides alternative ammonia removal pathways and prevents hyperammonemia. Apart from that, sodium benzoate, amino acid formulas and others are used.
The research further highlights the frontrunners, the drivers and barriers for the Urea Cycle Disorders market, as well as treatment algorithm, current treatments & advancements. The findings reveal that Urea cycle disorders treatment market is less competitive as few molecules and players are operating in the market place.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1265937
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com